Company intelligence / Profile preview
Genera Research Ltd.
Zagreb area, Croatiagenera-research.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Genera Research Ltd. develops recombinant human BMP-based products for tissue regeneration. Its lead candidate, OSTEOGROW using BMP6 in an autologous blood coagulum, has completed Phase II trials in orthopaedic indications and continues development in spinal fusion with European grant support. The company holds over 30 global patents related to its innovations.
- Therapeutic areas
- OtherRheumatologyNeurology
- Modalities
- Recombinant proteins (notably recombinant human Bone Morphogenetic Protein 6 - rhBMP6)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
European Union FP7 and Horizon2020 grants for clinical research consortia involving academic and medical partners
Beyond the preview
Go deeper on Genera Research Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Genera Research Ltd..